Board information
Our Board is responsible for the long-term success of GSK and membership includes the Company Chair, two Executive Directors, one non-independent and eight independent Non-Executive Directors.
Role and composition of our Board
Our Board is accountable to shareholders for ensuring that GSK is appropriately managed and achieves the strategic objectives it sets. The Board carries out its responsibilities through a programme of at least six scheduled meetings a year, which includes the approval of overall budgetary planning, as well as monitoring and scrutinising business strategy, performance and risk.
Our Board also has overall responsibility for succession planning for the CEO and other Executive Directors and it gives the CEO broad authority to operate the business of the group. The CEO is therefore accountable for business performance and reports back to the Board.
To learn more about our Board members access their individual biographies.
Board information
We strive to have a Board that encompasses a range and balance of skills, experience and knowledge complemented by different personal attributes, including character, intellect, judgement, honesty and courage. Our goal is to foster an inclusive environment where Board members can collaboratively challenge each other.
Directors' contracts
Each Executive Director has a contract of service with the company with a notice period on termination of 12 months by the employing company or the executive director.
Non-Executive Directors do not have service contracts. They have a letter of appointment.
Inspection of contracts and letters of appointment
Our Executive Directors' contracts of service and our Non-Executive Directors' letters of appointment with GSK or any of its subsidiaries are available for inspection at GSK House. Please contact the Company Secretary to arrange inspection at the following address:
Company Secretary
79 New Oxford Street
London
United Kingdom
WC1A 1DG
Visits can be arranged during normal business hours 09.00 to 17.00 (UK) (Saturdays, Sundays and public holidays excepted). The documents are also available for inspection at our Annual General Meeting each year for an hour before the meeting commences until the end of the meeting.
Independent external advice
There may be occasions when one or more of the directors require independent legal and/or financial advice regarding our business. GSK will reimburse the costs of obtaining this advice, provided that prior consent is first obtained from one of the following:
- the Chair of the Board
- any Deputy Chair or Senior Independent Director
- the Chair of the Audit & Risk Committee
Once consent is granted, the director must inform the Company Secretary that external advice is being sought. The Company Secretary will communicate any such notification to the Chair.
